Joshua A Kazam - Net Worth and Insider Trading
Joshua A Kazam Net Worth
The estimated net worth of Joshua A Kazam is at least $712,113 dollars as of 2024-06-10. Joshua A Kazam is the Director of Allogene Therapeutics Inc and owns about 258,885 shares of Allogene Therapeutics Inc (ALLO) stock worth over $600,613. Joshua A Kazam is also the Director of Target Hospitality Corp and owns about 10,000 shares of Target Hospitality Corp (TH) stock worth over $111,500. Details can be seen in Joshua A Kazam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua A Kazam has not made any transactions after 2022-01-12 and currently still holds the listed stock(s).
Transaction Summary of Joshua A Kazam
Joshua A Kazam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua A Kazam owns 17 companies in total, including Kronos Bio Inc (KRON) , Allogene Therapeutics Inc (ALLO) , and Flying Eagle Acquisition Corp (FEAC.U) among others .
Click here to see the complete history of Joshua A Kazam’s form 4 insider trades.
Insider Ownership Summary of Joshua A Kazam
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KRON | Kronos Bio Inc | 2020-10-08 | director |
ALLO | Allogene Therapeutics Inc | 2022-01-12 | director |
FEAC.U | Flying Eagle Acquisition Corp | 2020-03-05 | director |
2019-12-31 | director | ||
2019-03-05 | director | ||
2009-07-07 | director | ||
2017-09-28 | director | ||
2008-06-03 | director | ||
2004-01-28 | director | ||
2019-03-05 | director | ||
2020-03-05 | director | ||
2020-11-09 | director | ||
2021-02-23 | director | ||
2021-02-11 | director | ||
2022-01-05 | director | ||
2021-02-11 | director | ||
2020-11-09 | director |
Joshua A Kazam Latest Holdings Summary
Joshua A Kazam currently owns a total of 2 stocks. Among these stocks, Joshua A Kazam owns 258,885 shares of Allogene Therapeutics Inc (ALLO) as of January 12, 2022, with a value of $600,613 and a weighting of 84.34%. Joshua A Kazam also owns 10,000 shares of Target Hospitality Corp (TH) as of March 5, 2019, with a value of $111,500 and a weighting of 15.66%.
Latest Holdings of Joshua A Kazam
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALLO | Allogene Therapeutics Inc | 2022-01-12 | 258,885 | 2.32 | 600,613 |
TH | Target Hospitality Corp | 2019-03-05 | 10,000 | 11.15 | 111,500 |
Holding Weightings of Joshua A Kazam
Joshua A Kazam Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua A Kazam has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Allogene Therapeutics Inc is the acquisition of 15,000 shares on January 12, 2022, which cost Joshua A Kazam around $189,000.
According to the SEC Form 4 filings, Joshua A Kazam has made a total of 0 transactions in Target Hospitality Corp (TH) over the past 5 years. The most-recent trade in Target Hospitality Corp is the acquisition of 5,000 shares on March 5, 2019, which cost Joshua A Kazam around $51,000.
Insider Trading History of Joshua A Kazam
- 1
Joshua A Kazam Trading Performance
GuruFocus tracks the stock performance after each of Joshua A Kazam's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua A Kazam is -11.17%. GuruFocus also compares Joshua A Kazam's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua A Kazam within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua A Kazam's insider trading performs compared to the benchmark.
Performance of Joshua A Kazam
Joshua A Kazam Ownership Network
Ownership Network List of Joshua A Kazam
Ownership Network Relation of Joshua A Kazam
Joshua A Kazam Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Joshua A Kazam is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Joshua A Kazam made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Joshua A Kazam Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua A Kazam. You might contact Joshua A Kazam via mailing address: 689 5th Avenue, 12th Floor, New York Ny 10022.